U.S. markets open in 51 minutes

EV Biologics, Inc. (YECO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.90050.0000 (0.00%)
At close: 02:03PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.9005
BidN/A x N/A
AskN/A x N/A
Day's Range0.9005 - 0.9500
52 Week Range0.8500 - 6.3700
Avg. Volume3,038
Market Cap40.626M
Beta (5Y Monthly)-2.46
PE Ratio (TTM)N/A
EPS (TTM)-0.2290
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est32.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for YECO

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Daily – Vickers Top Buyers & Sellers for 09/29/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more

    EV Biologics Updates on NFT Dividend

    NASHVILLE, TN / ACCESSWIRE / November 12, 2021 / EV Biologics Corp, (OTC PINK:YECO), today updated shareholders with further details about its NFT dividend.The Company is still awaiting approval from FINRA for the distribution of the dividend.


    EV Biologics Signs Listing Agreement With INX

    NASHVILLE, TN / ACCESSWIRE / November 11, 2021 / EV Biologics Corp, ("the Company"), OTC PINK:YECO, today confirmed that it has signed an agreement to list its common stock on the INX Securities ATS, a regulated alternative trading system operated by INX Securities, LLC. INX Securities, LLC is the FINRA-member broker-dealer subsidiary of INX Limited.


    EV Biologics Chief Medical Officer Publication on COVID-19 & Exosomes

    NASHVILLE, TN / ACCESSWIRE / October 28, 2021 / EV Biologics Corp, OTC Pink:YECO, today updated shareholders about a recent publication authored by its Chief Medical Officer, Dr.This review discusses some of the cellular and molecular pathology of COVID-19 and the relevant therapeutic mechanisms of small extracellular vesicles (EVs), such as exosomes, in Acute Lung Injury (ALI).